Le Lézard
Classified in: Health, Science and technology
Subject: PLW

EXpressLO LLC Awarded U.S. Patent 11,808,679 for Cryo-EM Specimen Handling


EXpressLO LLC has been awarded U.S. Patent 11,808,679 from the USPTO for a unique cryogenic ex situ lift out specimen manipulation process for cryogenically prepared focused ion beam specimens. The cryo-EXLO methods and apparatus will increase throughput for cryo-EM characterization of vitreous biological specimens and beam sensitive materials.

LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials. EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.

"We anticipate cryo-EXLO manipulation of FIB specimens to facilitate throughput resulting in faster and statistically transformational research in cryo-EM in the fields of structural/cell biology and energy materials such as bacteria, virus infected cells and novel battery materials."

The novel methods and apparatus described in this U.S. patent were invented by EXpressLO LLC founder and President, Dr. Lucille A. Giannuzzi. The research and development supporting the inventions in this patent was funded by DOE BER SBIR award DE-SC0020511. EXpressLO LLC holds several other key U.S. patents related to FIB specimen preparation and manipulation processes (i.e., US 8,740,209; US 8,789,826; US 10,522,324; US 10,801,926). This latest cryo-EXLO patent builds on the foundations established by these prior EXLO-related patents.

The patented cryo-EXLO methods and instrumentation will assist cryo-EM researchers in both the life sciences and physical sciences. "Cryo-EXLO is a paradigm shift for manipulation of FIB lift out specimens prepared under cryogenic conditions," stated Dr. Giannuzzi. "We anticipate cryo-EXLO manipulation of FIB specimens to facilitate throughput resulting in faster and statistically transformational research in cryo-EM in the fields of structural/cell biology and energy materials such as bacteria, virus infected cells and novel battery materials."

EXpressLO LLC will showcase these methods and results at the following upcoming conferences/exhibits: 16thAnnual FIB SEM Meeting at Johns Hopkins Applied Physics Laboratory (APL) in Laurel, MD USA, May 22-23, 2024; Microscopy & Microanalysis 2024 in Cleveland, OH USA, July 28 - August 1, 2024; 20th World Congress on Structural Biology September 25-26, 2024, Paris, France.

For more information, please visit www.EXpressLO.com or contact Dr. Giannuzzi directly at info(at)EXpressLO(dot)com. Videos may be viewed at www.YouTube.com/LAGiannuzzi/videos.

Media Contact

Lucille Giannuzzi, EXpressLO LLC, 1 3216633806, [email protected], www.EXpressLO.com 

SOURCE EXpressLO LLC


These press releases may also interest you

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 11:49
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...

at 10:00
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week. "With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...

at 09:00
On Wednesday, Inman, the real estate industry's leading source of journalism, proudly announced the honorees of its 2024 Future Leaders in Real...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 07:00
SecureIQLab LLC, a leading provider of cloud security validation solutions, proudly unveils SocXtm, a groundbreaking AI-powered cloud validation platform. SocXtm introduces adaptive learning models for cyberattacks backed by powerful analytics...



News published on and distributed by: